trimethyloxamine has been researched along with Liver Cirrhosis in 3 studies
trimethyloxamine: used in manufacture of quaternary ammonium cpds; insect attractant; warming agent for gas; oxidant; structure
trimethylamine N-oxide : A tertiary amine oxide resulting from the oxidation of the amino group of trimethylamine.
Liver Cirrhosis: Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Betaine levels were positively associated with the CPT stage and MELD score (both p < ." | 1.91 | High plasma levels of betaine, a trimethylamine N-Oxide-related metabolite, are associated with the severity of cirrhosis. ( Bakker, SJL; Blokzijl, H; Connelly, MA; de Meijer, VE; Dullaart, RPF; Flores-Guerrero, JL; Garcia, E; van den Berg, EH, 2023) |
| "Non-alcoholic fatty liver disease (NAFLD) has become the most common chronic liver disease worldwide but still lacks specific treatment modalities." | 1.91 | Gut microbiota metabolite TMAO promoted lipid deposition and fibrosis process via KRT17 in fatty liver cells in vitro. ( Jin, N; Lu, X; Nian, F; Wu, L; Xia, Q; Zhu, C, 2023) |
| "Liver fibrosis is one main histological characteristic of nonalcoholic steatohepatitis (NASH), a disease paralleling a worldwide surge in metabolic syndromes with no approved therapies." | 1.72 | Trimethylamine-N-oxide (TMAO) mediates the crosstalk between the gut microbiota and hepatic vascular niche to alleviate liver fibrosis in nonalcoholic steatohepatitis. ( Ding, BS; Mo, C; Xiao, C; Zhang, J; Zhou, D, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| van den Berg, EH | 1 |
| Flores-Guerrero, JL | 1 |
| Garcia, E | 1 |
| Connelly, MA | 1 |
| de Meijer, VE | 1 |
| Bakker, SJL | 1 |
| Blokzijl, H | 1 |
| Dullaart, RPF | 1 |
| Zhou, D | 1 |
| Zhang, J | 1 |
| Xiao, C | 1 |
| Mo, C | 1 |
| Ding, BS | 1 |
| Nian, F | 1 |
| Zhu, C | 1 |
| Jin, N | 1 |
| Xia, Q | 1 |
| Wu, L | 1 |
| Lu, X | 1 |
3 other studies available for trimethyloxamine and Liver Cirrhosis
| Article | Year |
|---|---|
High plasma levels of betaine, a trimethylamine N-Oxide-related metabolite, are associated with the severity of cirrhosis.
Topics: Betaine; Biomarkers; Cohort Studies; End Stage Liver Disease; Humans; Liver Cirrhosis; Severity of I | 2023 |
Trimethylamine-N-oxide (TMAO) mediates the crosstalk between the gut microbiota and hepatic vascular niche to alleviate liver fibrosis in nonalcoholic steatohepatitis.
Topics: Animals; Disease Models, Animal; Gastrointestinal Microbiome; Liver Cirrhosis; Methylamines; Mice; N | 2022 |
Gut microbiota metabolite TMAO promoted lipid deposition and fibrosis process via KRT17 in fatty liver cells in vitro.
Topics: Fibrosis; Gastrointestinal Microbiome; Humans; Lipids; Liver Cirrhosis; Methylamines; Non-alcoholic | 2023 |